Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody
Francesca Casagrande, Stefania Bellone, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas Rutherford
Sunday, April 18, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 26
Mechanisms by which 2.3', 4,5' tetramethoxystilbene (TMS), a resveratrol derivative, induces death in breast cancer cells
Paula B. Aldo, Gil Mor
Sunday, April 18, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 4
Met (the HGF receptor) localizes to the nucleus in wound healing
Jennifer Bordeaux, Jason A. Hanna, Seema Agarwal, David L. Rimm
Sunday, April 18, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 9
Oncogenic tyrosine kinases phosphorylate and inhibit PKM2 to provide a metabolic advantage to tumor growth
Titus Boggon
Sunday, April 18, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 1
IGF-II promoter specific methylation patterns are associated with its expression and disease progression in epithelial ovarian cancer
Lingeng Lu, Dionyssios Katsaros, Biyun Qian, Herbert Yu
Sunday, April 18, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 31
Hypoxia-regulated Delta-like 1 homologue (DLK1) enhances cancer cell stemness and tumorigenicity
Daniel Zelterman, Zhong Yun
Sunday, April 18, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 16
Dual targeting of PI3K and mTOR results in synergistic growth inhibition in NSCLC cells
Herta H. Chao, Christopher Zito, Lucia Jilaveanu, Valsamo Anagnostou, David L. Rimm, Robert L. Camp
Monday, April 19, 9:00 AM - 12:00 PM
Exhibit Hall A-C, Poster Section 32
High expression of the microtubule destabilizing protein stathmin is prognostic for worse outcome in breast cancer
Maria Baquero, Jason Hanna, Seema Agarwal, Elizabeth Killiam, Robert L. Camp, David L. Rimm
Monday, April 19, 9:00 AM - 12:00 PM
Exhibit Hall A-C, Poster Section 30
Translational control analysis by translationally active RNA capture/microarray amalysis (TrIP-Chip)
Edward Chu
Monday, April 19, 9:00 AM - 12:00 PM
Exhibit Hall A-C, Poster Section 7
Anti CD30 chimeric immune receptor mRNA for therapy of CD30+ lymphomas
Pavel Karkanitsa, Sherman Weissman, Peter Rabinovich, Marina Komarovskaya, Francine Foss
Monday, April 19, 9:00 AM - 12:00 PM
Exhibit Hall A-C, Poster Section 37
Induction of pericyte migration by autotaxin in angiogenesis
Chi-yen Lin, Joshua Leinwand, Cheryl Maier, Jordan Pober, William Chang, Demetrios Braddock
Monday, April 19, 9:00 AM - 12:00 PM
Exhibit Hall A-C, Poster Section 12
Circulating tumor cells are rare in patients with curable oligometastatic cancer
Daniel Boffa, Xiaojie Guo, Annette Molinaro, Betsy Finan, Frank Detterbeck, David L. Rimm
Monday, April 19, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 11
A KRAS-variant as a putative biomarker of ovarian cancer risk
Joanne B. Weidhaas, Frank Slack
Monday, April 19, 9:00 AM - 12:00 PM
Exhibit Hall A-C, Poster Section 34
Complete characterization of prostate cancer genomes by massively parallel sequencing
Mark Gerstein
Monday, April 19, 9:00 AM - 12:00 PM
Exhibit Hall A-C, Poster Section 7
Identification of novel compounds that preferentially kill repair deficient cells using high-throughput screening
Elizabeth Peterson-Roth, Laura Abriola, Jane Merkel, Peter M. Glazer
Monday, April 19, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 9
Serum prostate health index and biopsy tissue DNA content at the time of diagnosis predicts the need for treatment in men enrolled in an active surveillance program
Danil Makarov
Monday, April 19, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 32
Accelerating the exploration of novel gene fusion events in prostate cancer
Andrea Sboner, Lukas Habegger, Mark B. Gerstein
Monday, April 19, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 32
Mitochondrial genetic variants influence ovarian cancer risk
Harvey Risch
Monday, April 19, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 36
A KRAS microRNA binding site polymorphism as a novel biomarker of risk in triple negative breast cancer
Trupti S. Paranjape, Cory Pelletier, Aaron Hoffman, Lyndsay Harris, Yong Zhu, Daniel Zelterman, David Tuck, Frank Slack, Joanne Weidhaas
Tuesday, April 20, 9:00 AM - 12:00 PM
Exhibit Hall A-C, Poster Section 4
Genomic amplification of IGF-1R in osteosarcoma
Jonathan Levin
Tuesday, April 20, 9:00 AM - 12:00 PM
Exhibit Hall A-C, Poster Section 9
Specific inhibition of IKK induces caspase-independent cell death in the ovarian cancer stem cells
Ayesha B. Alvero, Michele K. Montagna, Jennie Holmberg, Gil Mor
Tuesday, April 20, 9:00 AM - 12:00 PM
Exhibit Hall A-C, Poster Section 15
Farnesyltransferase inhibitor (FTI) disruption of Rheb/FKBP38 association leads to FKBP38-mediated inactivation of mTOR
Andrew D. Hamilton
Tuesday, April 20, 9:00 AM - 12:00 PM
Exhibit Hall A-C, Poster Section 30
Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in TM1 of ABCG2
Bradford Stanley
Tuesday, April 20, 9:00 AM - 12:00 PM
Exhibit Hall A-C, Poster Section 23
Transcriptional silencing of amplicons by histone deacetylase inhibition
Tae Hoon Kim, Yoon Jung Kim, Katharine R. Cecchini, Susan Radke, Amanika Kumar, Kimberly Geyda, Murli Narayan, David Tuck, Lyndsay Harris
Tuesday, April 20, 9:00 AM - 12:00 PM
Exhibit Hall A-C, Poster Section 2
Study of glioblastoma stem cell-like cancer stem cells on tumorigenesis and recurrence by multiple imaging modalities
Zhong Yun
Tuesday, April 20, 9:00 AM - 12:00 PM
Exhibit Hall A-C, Poster Section 16
A novel 3-biomarker quantitative protein assay predicts survival in stage I lung squamous cell carcinomas
Valsamo K. Anagnostou, Panagiota Kolokytha, Anastasios Dimou, Elizabeth J. Killiam, Lynn Tanoue, Frank Detterbeck, Konstantinos N. Syrigos, David L. Rimm
Tuesday, April 20, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 31
Altered helical structures: Repair and induction of genomic instability
Faye A. Rogers
Tuesday, April 20, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 3
A novel region on 8q24.21 is associated with ovarian cancer susceptibility
Harvey Risch
Tuesday, April 20, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 34
Wound repair promotes ovarian cancer stem cell self-renewal
Ilana Chefetz-Menaker, Noah Lebowitz, Paolomi Aldo, Ayesha Alvero, Jennie Holmberg, Gil Mor
Tuesday, April 20, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 14
Comprehensive isoform expression analysis reveals that EGFR and sEGFR are prognostic determinants of cancer
Jason A. Wilken, Nita J. Maihle
Tuesday, April 20, 2:00 - 5:00 PM
Exhibit Hall A-C, Poster Section 31
Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis
Wook Jin Chae, Octavian Henegariu, Daniel Zelterman, Liming Hao, Thomas Gibson, Alfred Bothwell
Wednesday, April 21, 8:00 - 11:00 AM
Exhibit Hall A-C, Poster Section 18
Autophagy in malignant melanoma and breast carcinoma
Rossitza Lazova, Vincent Klump, Summar Siddiqui, Robert L. Camp, John Pawelek
Wednesday, April 21, 8:00 - 11:00 AM
Exhibit Hall A-C, Poster Section 10
Cytoplasmic expression of estrogen receptors in breast cancers
Young J. Choi
Wednesday, April 21, 8:00 - 11:00 AM
Exhibit Hall A-C, Poster Section 33
Sumaira Z. Aasi, MD, Dermatology
Jean L. Bolognia, MD, Dermatology
Irwin M. Braverman, MD, Dermatology
John W. Colberg, MD, Surgery, Urology
Dennis Cooper, MD, Hematology
Frank C. Detterbeck, MD, Surgery, Thoracic
Thomas Duffy, MD, Hematology
Charles C. Duncan, MD, Neurosurgery
Richard L. Edelson, MD, Dermatology
Gary D. Friedlaender, MD, Orthopedics
Michael Girardi, MD, Dermatology
Peter W. Heald, MD, Dermatology
Elizabeth Holt, MD, Endocrinology
Suguru Imaeda, MD, Dermatology
David J. Leffell, MD, Dermatology
Walter E. Longo, MD, Surgery, Gastroenterology
Peter W. Marks, MD, Hematology
Elias M. Michaelides, MD, Otolaryngology
Joseph M. Piepmeier, MD, Neurosurgery
Ronald Salem, MD, Surgical Oncology
Clarence T. Sasaki, MD, Otolaryngology
